Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Cardiometabolic Risk Factors and COVID-19 in the Asia-Pacific Region
Author(s): Ru Ying Fong , Annie Lee , Fei Gao , et al Added: 1 year ago

Vascular Disease and Surgery

COVID-19
FLOW: Kidney, Cardiovascular, Mortality, Metabolic and Safety Results
Author(s): Richard Pratley Added: 7 months ago
EASD 24 - We are joined by Dr Richard Pratley (AdventHealth Diabetes Institute, US) to discuss the kidney, cardiovascular, metabolic, mortality and safety results from the FLOW trial.Interview Questions:1. What is the reasoning behind the FLOW Trial?2. What was the patient population and study design?3. What are the key results?4. Were there any surprising or unexpected findings?5. What further… View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
AHA 23: ECLS-SHOCK: Impact of Cardiac Arrest on the Efficacy of ECLS Patients
Author(s): Uwe Zeymer Added: 1 year ago
AHA 23 - We are joined on-site by Prof Uwe Zeymer (Klinikum Ludwigshafen, Ludwigshafen, DE) to discuss the findings from a sub-analysis of the ECLS-SHOCK trial.This sub-analysis investigates the impact of cardiac arrest before randomisation on the efficacy of ECLS in patients with infarct-related cardiogenic shock. Investigators enrolled 420 patients with acute MI and cardiogenic shock across 41… View more

Heart Failure

Prevention & Chronic Conditions
Hospitalised HF: Ejection Fraction Analysis (MY-HF Registry).
Author(s): Wan Azman Wan Ahmad , Abdul Kahar Abdul Ghapar , Azmee Mohd Ghazi , et al Added: 1 month ago

Heart Failure
Hospital Frailty Risk Score in Heart Failure
Author(s): Zhenwei Teo , Ying Zi Oh , Weiliang Huang , et al Added: 11 months ago

Guidelines & Statements

Heart Failure
CRT 25: Insights from the GUARD Study
Author(s): Baravan Al-Kassou Added: 1 month ago
CRT 25 - Insights on the progression risk in patients with mild to moderate aortic stenosis (AS) show that there was no significant difference in progression rates between mild and moderate AS. However, moderate AS patients had significantly higher mortality rates than mild AS patients at one- and two-year follow ups. The study also suggests that elevated phosphate levels and elevated… View more

Vascular Disease and Surgery
TCT 23: WATCH-TAVR: WATCHMAN for Patients with AF Undergoing TAVR
Author(s): Samir R Kapadia Added: 1 year ago
TCT 23 - We are joined by Dr Samir Kapadia (Cleveland Clinic, Cleveland, OH) to discuss the findings of the WATCH-TAVR Trial (NCT03173534). WATCH-TAVR aimed to evaluate the safety and effectiveness of left atrial appendage occlusion with the WATCHMAN device to prevent stroke and bleeding in patients with atrial fibrillation (AF) who are undergoing transcatheter aortic valve replacement (TAVR)… View more

Electrophysiology & Arrhythmia

Intervention
ESC 24: The EARTH-STEMI Meta-Analysis
Author(s): Gianluca Campo Added: 7 months ago
ESC Congress 2024 — Complete revascularisation is safe, reduces ischemic events for up to 4 years, and does not affect long-term mortality.We are joined onsite by Dr Gianluca Campo (University of Ferrara, Ferrara, IT) to discuss the findings from EARTH-STEMI. Previous RCTs have supported the benefit of complete revascularisation in the overall population, however, this has not been confirmed in… View more

Intervention
ESC 23 Late-Breaker Discussion: The ECLS-Shock Trial
Author(s): Harriette Van Spall , Holger Thiele Added: 1 year ago
ESC 2023 – Late-Breaker host, Dr Harriette Van Spall (McMaster University, CA) is joined by Prof Holger Thiele (Heart Center Leipzig at University of Leipzig, DE) to discuss the findings from the ECLS-SHOCK trial (NCT03637205). The leading cause of death in hospitalised patients with acute myocardial infarction is cardiogenic shock. Efforts to improve outcomes for these patients has led to… View more

Heart Failure

Intervention
TCT 24: The EVOLVED Trial
Author(s): Marc Dweck Added: 5 months ago
TCT Conference 2024 - Clinical outcomes of early intervention in patients with asymptomatic aortic stenosis (AS) did not impact the composite primary outcome of all cause mortality and unplanned AS related hospitalisation.Dr Marc Dweck (University of Edinburgh, Edinburgh, UK) joins us in this short interview filmed onsite at TCT Conference to discuss the findings from EVOLVED (NCT03094143;… View more

Imaging & Diagnostics